MAPT and Alzheimer disease: Furthermore, the ability of Aβ to enhance tau pathology, similar to what is speculated to occur in AD, has been demonstrated in several in vitro experiments, using tau seeding assays, and in vivo experiments, using transgenic and wild‐type mice 23, 24, 25, 26.